Meta Stock: Is It Time for Investors to Buy the Dip?

Meta reported strong Q1 results, with revenue up 33% year over year to $56.3 billion, operating margin at 41%, and free cash flow rising to $12.4 billion. The key negative was management raising 2026 capex guidance to $125 billion-$145 billion from $115 billion-$135 billion, implying a near-doubling versus last year's $72 billion and pressuring the stock. Reality Labs posted about a $4 billion operating loss, while legal headwinds in the EU and U.S. remain a risk.

Analysis

The market is treating Meta’s higher capex guide as if it is pure margin destruction, but the more important signal is competitive escalation. Meta is effectively choosing to pre-commit to frontier-scale infrastructure spend, which can pressure peers into either matching intensity or accepting a slower AI product cadence; that is bullish for the large-cap compute stack, especially NVIDIA, but only if the capex is deployed fast enough to absorb supply. The near-term risk is that the stock is repriced on the denominator first and the earnings power later, creating a mismatch that can persist for several quarters.

The bigger second-order issue is that Meta’s optionality cuts both ways: if model returns disappoint, it can slow deployments, but it still has to carry the depreciation and power commitments already baked into the buildout. That means operating leverage likely peaks before the market gives it credit, and the earnings drag from this capex cycle may show up gradually over 6-12 months rather than immediately. This is why the current drawdown can be larger than the fundamental damage today, yet still leave the stock vulnerable to additional multiple compression if the market decides free cash flow is being structurally re-rated.

Contrarian read: the consensus is anchoring on the spending headline and underestimating how much of Meta’s core ad engine is still accelerating underneath it. If ad pricing and impression growth remain constructive for another quarter, the bear case shifts from "too much spend" to "proof-of-inferior capital allocation," which is a much harder case to sustain without evidence of deceleration. The legal and Reality Labs overhangs matter, but they are longer-dated; the immediate trading axis is whether investors rotate from penalizing capex to rewarding revenue acceleration and AI monetization optionality. That inflection could be abrupt if management signals that spend is front-loaded and then normalizes.

Key Decisions for Investors

• Buy META into post-earnings weakness on a 1-3 month horizon; target a mean reversion rebound if the market realizes capex is front-loaded, but keep a tight stop if multiple compression persists below ~20x forward earnings.
• Pair trade: long NVDA / short META for a 2-6 week window if you want to isolate infrastructure beneficiaries while avoiding single-name capex overhang; the risk is that META re-rates faster than expected and squeezes the short.
• Sell META downside via put spreads 2-4 months out; structure to monetize elevated fear around capex while defining risk, since the stock can stay volatile until the market gets another data point on ad growth and spend pacing.
• Avoid chasing META outright if you are underweight liquidity risk; wait for confirmation on next-quarter revenue continuation and capex normalization comments before adding size.
• If you own META, consider partially hedging with a short Nasdaq beta overlay for the next earnings cycle, because the stock is likely to trade more like a capital-intensive AI infrastructure story than a pure ad compounder near term.